Bryan Giraudo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan Giraudo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bryan Giraudo. Bryan Giraudo is Director in Protagonist Therapeutics, Inc ($PTGX) and Chief Financial Officer in Gossamer Bio, Inc. ($GOSS).
Latest Insider Trading Transactions of Bryan Giraudo
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
| Jun 23 2020 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 12.96 | 2,000 | 25,922 | 4,121 | 2.1 K to 4.1 K (+94.30 %) |
| May 29 2020 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| Dec 03 2019 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Buy | P | 5.70 | 8,000 | 45,620 | 8,000 | 0 to 8 K |
| Sep 26 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 16.78 | 1,121 | 18,810 | 2,121 | 1,000 to 2.1 K (+112.10 %) |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 03 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 18.70 | 1,000 | 18,700 | 1,000 | 0 to 1,000 |
| Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 22.10 | 145,000 | 3,204,500 | 145,000 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | C | 0.00 | 23,316 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | C | 0.00 | 57,142 | 0 | 0 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 16.00 | 6,000 | 96,000 | 23,879 | 17.9 K to 23.9 K (+33.56 %) |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | C | 0.00 | 17,879 | 0 | 17,879 | 0 to 17.9 K |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| May 17 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 6.45 | 24,000 | 154,800 | 24,000 | |
| May 17 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Buy | P | 6.46 | 10,000 | 64,566 | 10,000 | 0 to 10 K |
Page: 1